HILLIARY MAHLER: Open Payments
NPI 1275380115 · PERRY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 80 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $554 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $275 |
| ABBVIE INC. | 20 | $190 |
| Neurocrine BioSciences, Inc. | 21 | $169 |
| Corium, LLC | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Itamar Medical Inc | 1 | $29 |
| Neos Therapeutics, LP | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: VRAYLAR, REXULTI, INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, Azstarys, FANAPT, WatchPATONE.
Industry payments across IA — which companies pay providers there.
